Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Known variant vs. genome wide: which PRS is better for prostate cancer?
From the Darst Lab, Public Health Sciences Division
Transformative $78M gift to establish new precision oncology institute
Gift will accelerate center’s leadership in the future of cancer research
Could gene twins team up against cancer?
New approach uncovers gene duplications that could be targets for cancer drugs
New study shows cancer-causing ‘Frankengene’ mutation could be target for new drugs
This gene is fused to many partner genes in different tumors. Now, scientists know it causes cancer — and how they might intervene
In cancer, the context 'makes' the mutation
Whether a mutated gene suppresses or promotes small-cell lung cancer depends on other mutations
Cancer cells reconnect with their inner child to evade immunotherapy
Turning on an embryonic gene may help some tumors resist immune checkpoint inhibitors
Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene
‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment
Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’
Predicting ovarian cancer by counting tumor-attacking immune cells
Study led by Jason Bielas finds new way to quantify immune cells reliably, quickly and cheaply
Fred Hutchinson Cancer Research Center Investigators Use Guilt-by-Association Strategy to Track Potential Cancer Causing Genes
Represents a key step toward the quest by cancer biologists to characterize the cellular pathways that distinguish one type of cancer from another